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Supplementary Information 
1. Single β2 < α4 Interface  
Figure S1. presents calculations for a subunit order containing only a single β2<α4 
interface. The top panel presents a table of jin ,  values extending Figure 1D, and including 
the jin ,  values for the single-interface structure. The equations for 3,22,3 / EE  and 
3,22,3 / NFRETNFRET  are derived by analogy to Equations 2 through 9. Panels A through 
D present the results. For this model, the simulations depend more strongly on the 
geometry factor G than on the asymmetry factor Δ; therefore plots with G on the y-axis are 
presented in C and D.  
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Figure S1. Cont. 
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2. Stoichiometry-Dependent Changes in AI  or 
'
Df  
Distortions in 3,22,3 / NFRETNFRET  could arise from factors that render AI  different for the two 
stoichiometries. We have not systematically studied this possibility; but it should be considered in 
view of the reports about dead-end intermediates in assembly of nAChRs [1,2], as well as reports that 
degradation could occur differentially for the two stoichiometric forms [3].  
To simulate an effect of stoichiometry on AI , we define the parameter e, which increases AI  for the 
three-acceptor stoichiometry more than for the two-acceptor stoichiometry. We write, for the 
(α4)2(β2)3 stoichiometry,  
eeI A 3)1( +−= ; 
for the (α4)3(β2)2 stoichiometry, 
eeI A 2)1( +−= . 
Figure S2 presents the calculations for 3,22,3 / NFRETNFRET  resulting from the assumption that  
e = 0.2. Evidently the major result is to decrease the expected measured 3,22,3 / NFRETNFRET  ratios. 
If the sign of e is reversed, the expected 3,22,3 / NFRETNFRET  ratios increase. Thus, e = −0.2 predicts 
3,22,3 / NFRETNFRET  > 1.2 for all aveR ,1 > ~25 Å (not shown), or essentially outside the measured 
range of data. 
Variations in 'Df  could arise as follows. If 5.0=Pf , then ( ) %7511 2 =−− Pf  of donors in 
(α4)2(β2)3 nAChRs participate in FRET; but ( ) %5.8711 3 =−− Pf  of donors in (α4)3(β2)2 nAChRs 
participate in FRET. This would affect the DI  factor in Equation 8 and would be simulated with a 
term containing e, similar to those above. The expected effects would be of similar magnitude to those  
of Figure S2.  
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Figure S2. Calculations for 3,22,3 / NFRETNFRET  resulting from the assumption that e = 0.2. 
fP = 0.5, e = 0.2
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3. Net FRET Analyses 
Measurements of net FRET utilize DAI , uncorrected for total donor or acceptor intensity. Figure S3 
presents net FRET distributions for the two manipulations of this study: biased transfections and 48 h 
drug treatment. The untransformed data are evidently not suited for analysis by statistics that assume 
normal distributions. We have therefore simply computed the mean across all pixels. The mean net 
FRET values do follow the same trend of the values for NFRET , and for highW . The lowest values are 
recorded for the higher mole fraction of β2 cDNA and for incubation in nicotine; the highest values are 
recorded for the lower mole fraction of β2 cDNA and for incubation in cytisine. In the biased subunit 
experiment, the ratio between lowest and highest values for net FRET (1.29) is quite consistent with 
the values simulated for inter-fluorophore distances of 35–50 Å. In the pharmacological chaperoning 
experiment, the analogous value is 1.27, not markedly different. Evidently the net FRET measurements 
lack the power to resolve the subtle differences resolved in the NFRET experiments. Also note that, for 
the identical conditions (0.5 mole fraction β2 cDNA, no drug treatment), the absolute values of the net 
FRET means differ between the two experiments, as expected for variations among cell batches, 
transfection efficiency, and other factors; these variables are largely eliminated in NFRET 
experiments. Thus the net FRET analyses, while modestly reinforcing the qualitative conclusions 
about stoichiometry observed in the NFRET experiments, are less useful than the latter.  
Figure S3. Pixel distributions for net FRET in experiments that vary (A) mole fraction β2 
mRNA or (B) 48 h drug treatment. Each sample had >106 pixels. 
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